TOCILIZUMAB SIGNIFICANTLY REDUCES SERUM AMYLOID A IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER - DATA FROM THE PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TOFFIFE STUDY

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2022
This article has no abstract
Epistemonikos ID: 212c550ff2dd67c2e752cdb03691c31bf509f24c
First added on: Feb 15, 2025